JPH3 and lung adenocarcinoma: In lung adenocarcinoma, JPH3 was downregulated 0.2-fold by S100A2 (associated with favorable prognosis in p53-negative tumors) and 0.43-fold by S100A4 (associated with poor prognosis in p53-positive tumors) [131].